Data / Form D filings / IN8BIO, INC.
IN8BIO, INC.: Form D filings
IN8BIO, INC., a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on December 30, 2025, reports $20.1 million sold of a $40.2 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, New York, NY, 10118
- Phone
- (646) 600-6438
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1740279
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | New notice | $40,239,043 | $20,119,049 | $20,119,994 | 17 | Dec 22, 2025 | sec.gov |
| Oct 15, 2024 | New notice | $12,379,983 | $12,379,983 | 73 | Oct 4, 2024 | sec.gov | |
| Dec 28, 2023 | New notice | $14,425,013 | $14,425,013 | 20 | Dec 13, 2023 | sec.gov | |
| Sep 4, 2020 | Amendment | $34,980,581 | $34,980,581 | 33 | May 7, 2018 | sec.gov | |
| Sep 20, 2018 | Amendment | $10,000,000 | $8,812,156 | $1,187,844 | 25 | May 7, 2018 | sec.gov |
| May 22, 2018 | New notice | $8,000,000 | $4,757,530 | $3,242,470 | 13 | May 7, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Luba R. Greenwood | Director | |
| Lawrence R. Lamb | Executive Officer | |
| William Ho | Executive Officer, Director | |
| Peter S. Brandt | Director | |
| Jeremy R. Graff | Director | |
| Kate R. Rochlin | Executive Officer | |
| Emily R. Fairbairn | Director | |
| Corinne R. Epperly | Director | |
| Alan S. Roemer | Director | |
| Patrick McCall | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IN8BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.